Overview
An anthelmintic used in most schistosome and many cestode infestations.
Indication
For the treatment of infections due to all species of schistosoma.
Associated Conditions
- Cestode infections
- Cysticercosis
- Liver fluke infection
- Trematode infections
- Schistosoma infection
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2022/04/29 | Not Applicable | UNKNOWN | |||
2020/12/22 | Phase 2 | Completed | |||
2020/11/19 | N/A | UNKNOWN | |||
2020/03/18 | Phase 1 | Completed | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | ||
2019/10/03 | Phase 2 | Completed | Vendsyssel Hospital | ||
2019/03/28 | Phase 3 | Completed | Institute of Tropical Medicine, Belgium | ||
2019/02/19 | Phase 3 | Completed | |||
2018/12/19 | Phase 3 | UNKNOWN | Centre de Recherche Médicale de Lambaréné | ||
2018/08/21 | Phase 2 | UNKNOWN | |||
2018/02/19 | Phase 1 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Central Texas Community Health Centers | 76413-146 | ORAL | 600 mg in 1 1 | 8/23/2017 | |
| Bayer HealthCare Pharmaceuticals Inc. | 50419-747 | ORAL | 600 mg in 1 1 | 12/6/2023 | |
| Virbac AH Inc | 51311-087 | ORAL | 125 mg in 1 1 | 6/11/2025 | |
| Par Pharmaceutical, Inc. | 49884-231 | ORAL | 600 mg in 1 1 | 5/29/2019 | |
| Virbac AH Inc | 51311-088 | ORAL | 250 mg in 1 1 | 6/11/2025 | |
| Virbac AH Inc | 51311-089 | ORAL | 25 mg in 1 1 | 6/11/2025 | |
| Virbac AH Inc | 51311-086 | ORAL | 25 mg in 1 1 | 6/11/2025 | |
| Elanco US Inc. | 58198-0064 | ORAL | 34 mg in 1 1 | 5/21/2025 | |
| Virbac AH Inc | 51311-091 | ORAL | 250 mg in 1 1 | 6/11/2025 | |
| Virbac AH Inc | 51311-090 | ORAL | 125 mg in 1 1 | 6/11/2025 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| DISTOCIDE TABLET 600 mg | SIN06822P | TABLET, FILM COATED | 600 mg | 2/6/1992 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Praziquantel Tablets | 国药准字H20058072 | 化学药品 | 片剂 | 9/29/2020 | |
| Praziquantel Tablets | 国药准字H42021276 | 化学药品 | 片剂 | 6/17/2020 | |
| Praziquantel Tablets | 国药准字H20093670 | 化学药品 | 片剂 | 3/5/2024 | |
| Praziquantel Tablets | 国药准字H32021380 | 化学药品 | 片剂 | 7/22/2020 | |
| Praziquantel Tablets | 国药准字H20023773 | 化学药品 | 片剂（薄膜衣） | 4/9/2020 | |
| Praziquantel Tablets | 国药准字H32021731 | 化学药品 | 片剂 | 6/22/2020 | |
| Praziquantel Tablets | 国药准字H20003120 | 化学药品 | 片剂 | 5/19/2020 | |
| Praziquantel Tablets | 国药准字H22025017 | 化学药品 | 片剂 | 2/19/2020 | |
| Praziquantel Tablets | 国药准字H31020485 | 化学药品 | 片剂 | 9/18/2020 | |
| Praziquantel Tablets | 国药准字H41020746 | 化学药品 | 片剂 | 6/17/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| BILTRICIDE Praziquantel 600mg Tablets | 18845 | Medicine | A | 10/8/1991 |
Help Us Improve
Your feedback helps us provide better drug information and insights.